Anti myeloperoxidase mpo

Manufactured by Agilent Technologies

Anti-myeloperoxidase (MPO) is a laboratory equipment product that detects the presence of myeloperoxidase, an enzyme found in certain white blood cells. It is used to measure MPO levels in clinical samples.

Automatically generated - may contain errors

Lab products found in correlation

Anti ki67, by Agilent Technologies (1 mentions) Envision hrp, by Agilent Technologies (1 mentions) Anti cd3, by Abcam (1 mentions) Anti von willebrand factor, by Abcam (1 mentions) P06dhurb, by Thermo Fisher Scientific (1 mentions) Anti fibrinogen, by Agilent Technologies (1 mentions) Anti ly6g, by Thermo Fisher Scientific (1 mentions) Anti mx1, by Proteintech (1 mentions)

Close spelling variants of this product

Rabbit anti-myeloperoxidase (MPO, Anti-Myeloperoxidase (MPO) antibody (A0398) Myeloperoxidase (MPO; Anti-myeloperoxidase Anti-MPO Anti-TM

3 protocols using anti myeloperoxidase mpo

Immunohistochemical Evaluation of Esophageal Protein Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols

The protein expression of resected esophageal specimens was evaluated by immunohistochemistry. After pretreatment, each section was treated with the following primary antibodies: anti-pancytokeratin, anti-Ki67, anti-myeloperoxidase (MPO) (Dako), anti-inducible nitric oxide synthase (iNOS) (Abcam), and anti-CD3 (Abcam). All sections were treated with a secondary antibody (EnVision™/HRP, Dako), and hematoxylin was used for counterstaining. The clone, code, dilution, and antigen retrievals of immunohistochemistry are summarized in Supplemental Table 1.

Kobayashi S., Kanai N., Yamato M, & Eguchi S. (2022). Allogeneic transplantation of epidermal cell sheets followed by endoscopic submucosal dissection to prevent severe esophageal stricture in a porcine model. Regenerative Therapy, 21, 157-165.

+ Open protocol

+ Expand

Immunostaining of Thrombosis Biomarkers

Check if the same lab product or an alternative is used in the 5 most similar protocols

Freshly recovered thrombi were fixed in 3.7% paraformaldehyde for 48 h before being embedded longitudinally in paraffin and sectioned at 5 µm. Immunostainings were performed as described previously²⁷ (link) using the following primary antibodies: anti‐fibrinogen (20 µg/ml; Dako, ref A0080), anti‐Von Willebrand factor (10 µg/ml; Abcam, ref ab11713), anti‐CD42b (2 µg/ml; Beckman Coulter, ref IM0409), anti‐platelet factor 4 (10 µg/ml; Peprotech, ref 500‐P05), anti‐myeloperoxidase (MPO, 10 µg/ml; Dako, ref A0398), anti‐histone H4 citrulline 3 (H4Cit, 1/200; Millipore, ref 07‐596), anti‐angiotensin‐converting enzyme 2 (ACE‐2, 3 µg/ml, R&D Systems, ref AF933), and anti‐SARS‐CoV‐2 Spike Protein (5 µg/ml, P06DHuRb and T01KHuRb from Invitrogen, 10 µg/ml 40150‐R007 from Sino Biological). Red blood cells were identified by their autofluorescence (λex 440/9/λem > 570 nm).

Desilles J., Solo Nomenjanahary M., Consoli A., Ollivier V., Faille D., Bourrienne M., Hamdani M., Dupont S., Di Meglio L., Escalard S., Maier B., Blanc R., Piotin M., Lapergue B., Ajzenberg N., Vasse M., Mazighi M., Ho‐Tin‐Noé B., Désilles J., Mazighi M., Piotin M., Blanc R., Redjem H., Smajda S., Seners P., Escalard S., Delvoye F., Maier B., Hebert S., Ben Maacha M., Hamdani M., Sabben C., Obadia M., Deschildre C., Lapergue B., Consoli A., Rodesch G., Maria F., Coskun O., Lopez D., Bourcier R., Detraz L., Desal H., Roy M., Clavier D., Marnat G., Gariel F., Lucas L., Sibon I., Eugene F., Vannier S., Ferre J., LeBras A., Raoult H., Paya C., Gauvrit J., Richard S., Gory B., Barbier C., Vivien D., Touze E., Gauberti M., Blaizot G., Ifergan H., Herbreteau D., Bibi R., Janot K., Charron V, & Boulouis G. (2022). Impact of COVID‐19 on thrombus composition and response to thrombolysis: Insights from a monocentric cohort population of COVID‐19 patients with acute ischemic stroke. Journal of Thrombosis and Haemostasis, 20(4), 919-928.

+ Open protocol

+ Expand

Immunofluorescence Staining and Histopathology

Check if the same lab product or an alternative is used in the 5 most similar protocols

Endothelial function studies were performed as reported by us.^{11 (link)} Immunofluorescence staining for kidney IgG and C3 was performed on frozen sections as described.^{11 (link)} Skin and kidney frozen sections were stained with rabbit polyclonal anti-myeloperoxidase (MPO) (Dako) and rat monoclonal anti-Ly-6G (eBioscience). For kidney histopathology, formalin-fixed sections were scored in a blinded manner as described.^{11 (link)} Formalin-fixed kidney and skin sections were also stained with anti-Mx1 (Proteintech).

Knight J.S., Subramanian V., O’Dell A.A., Yalavarthi S., Zhao W., Smith C.K., Hodgin J.B., Thompson P.R, & Kaplan M.J. (2014). Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice. Annals of the rheumatic diseases, 74(12), 2199-2206.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!